GoldenGolden
Norbert Bischofberger

Norbert Bischofberger

Austrian biochemist, developed tamiflu, truvada and sofosbuvir

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

January 10, 1954
Norbert Bischofberger was born in Mellau.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Amirah Al Idrus
January 12, 2021
FierceBiotech
This year's virtual J.P. Morgan Healthcare Conference could be a "reset" that changes the trajectory of the meeting and its attendant events. Biopharma executives and their colleagues in communications and PR weighed in on what that means for 2021 and beyond.
Nick Paul
July 16, 2020
FierceBiotech
Ex-Gilead CSO Norbert Bischofberger has struck a deal with his former employer. The agreement will see Bischofberger's Kronos Bio buy Gilead's portfolio of spleen tyrosine kinase inhibitors and vault into clinical development.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.